People: Novartis AG (NOVN.VX)

NOVN.VX on Virt-X Level 1

92.45CHF
10:09am EST
Price Change (% chg)

CHF0.35 (+0.38%)
Prev Close
CHF92.10
Open
CHF94.30
Day's High
CHF94.45
Day's Low
CHF92.10
Volume
12,914,785
Avg. Vol
5,248,414
52-wk High
CHF94.45
52-wk Low
CHF69.20

Search Stocks

Galen, Michele 

Brief Biography

Ms. Michele Galen serves as Head Communications of Novartis AG since January 2012. Prior to this appointment, Ms. Galen served as Vice President and Global Head, Communications and Advocacy for Novartis Pharmaceuticals, based in Basel, Switzerland. Ms. Galen joined Novartis Pharmaceuticals Corporation (NPC) in the US in 2001. During her tenure at Novartis, she also served as Vice President and Global Head, Oncology Affairs; Vice President and Global Head, Communications and External Affairs for Novartis Molecular Diagnostics; and Vice President, Corporate Communications, NPC. Prior to joining Novartis Pharmaceuticals, Ms. Galen was a Managing Director in the Corporate Practice at a global public relations firm in New York specializing in change communication, issues management and strategic philanthropy. She also is an award-winning journalist, was Editor at Business Week magazine and served as a board member of the Global Health Council. She is a member of the New York State Bar and practiced at Stroock, Stroock + Lavan, and Skadden, Arps, Slate, Meagher & Flom. Ms. Galen received a B.A. from George Washington University, a master’s degree from the Columbia University Graduate School of Journalism, and a J.D. from New York University School of Law.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Joerg Reinhardt

1,900,810

Joseph Jimenez

13,226,300

Ulrich Lehner

1,328,210

Harry Kirsch

2,344,290

Peter Kornicker

--

Felix Ehrat

4,321,510
As Of 30 Dec 2013
Search Stocks